Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of X A-DERM™ Microsurfaced Acellular Dermal Matrix (mADM) for Enhancing Wound Healing Following Mohs Micrographic Surgery (MMS)

NCT06919809 is registered in ClinicalTrials.gov with McGuire Institute as lead sponsor.

NCT NCT06919809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06919809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of X A-DERM™ Microsurfaced Acellular Dermal Matrix (mADM) for Enhancing Wound Healing Following Mohs Micrographic Surgery (MMS)
Lead sponsor
McGuire Institute
Phase
Not applicable
Overall status
Completed
Start date
August 8, 2025
Completion date
March 6, 2026
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bcc - basal cell carcinoma, melanoma in situ, scc - squamous cell carcinoma, wound healing after mms surgery